Impact of Genetic Targets on Cancer Therapy
Editat de Wafik S. El-Deiryen Limba Engleză Paperback – 8 feb 2015
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 1389.69 lei 6-8 săpt. | |
Springer – 8 feb 2015 | 1389.69 lei 6-8 săpt. | |
Hardback (1) | 1394.16 lei 6-8 săpt. | |
Springer – 4 ian 2013 | 1394.16 lei 6-8 săpt. |
Preț: 1389.69 lei
Preț vechi: 1462.83 lei
-5% Nou
Puncte Express: 2085
Preț estimativ în valută:
266.00€ • 278.92$ • 219.78£
266.00€ • 278.92$ • 219.78£
Carte tipărită la comandă
Livrare economică 29 ianuarie-12 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781489991447
ISBN-10: 1489991441
Pagini: 456
Ilustrații: VIII, 448 p.
Dimensiuni: 155 x 235 x 24 mm
Greutate: 0.64 kg
Ediția:2013
Editura: Springer
Colecția Springer
Locul publicării:New York, NY, United States
ISBN-10: 1489991441
Pagini: 456
Ilustrații: VIII, 448 p.
Dimensiuni: 155 x 235 x 24 mm
Greutate: 0.64 kg
Ediția:2013
Editura: Springer
Colecția Springer
Locul publicării:New York, NY, United States
Public țintă
ResearchCuprins
Novel antineoplastics targeting genetic changes in colorectal cancer.- Update on Clinical Trials: Genetic Targets in Breast Cancer.- Impact of Genetic Targets on Cancer Therapy in Esophagogastric Cancer.- Impact of Genetic Targets on Cancer Therapy: Liver Cancer.- Targeting the molecular phenotype of pancreatic cancer toward the goal of patient-tailored therapy.- Impact of genetic markers on treatment of Non-small cell lung cancer.- Impact of Genetic Targets on Therapy in Head and Neck Squamous Cell Carcinoma.- Tyrosine Kinase Targeted Treatment of Chronic Myelogenous Leukemia and Other Myeloproliferative Neoplasms.- Targeted Therapy of Multiple Myeloma.- Current and Future Trials of Targeted Therapies in Cutaneous Melanoma.- Current Approaches to Epigenetic therapy for the treatment of Mantle Cell Lymphoma.- Impact of Genetic Targets on Primary Brain Tumor Therapy: What’s Ready for Prime Time?.- Rational therapy for renal cell carcinoma based on its genetic targets.- Molecular and Genetic Markers of Follicular-Cell Thyroid Cancer: Etiology and Diagnostic and Therapeutic Opportunities.- Genetic Targets in Pediatric Acute Lymphoblastic Leukemia.- Emerging molecular therapies for the treatment of Acute Lymphoblastic Leukemia.- Impact of Genetic Targets on Prostate Cancer Therapy.- Small-Cell Lung Cancer: An Update on Targeted Therapies.- Impact of Genetic Targets on Cancer Therapy in Acute Myelogenous Leukemia.- Index.
Notă biografică
Wafik S. El-Deiry, M.D., Ph.D, is Professor of Medicine, Chief, Hematology/Oncology, Rose Dunlap Division Chair in Hematology/Oncology, and Associate Director for Translational Researchat Penn State Hershey Cancer Institute. Dr. El-Deiry is a well-respected and notable figure among cancer researchers, scientists, and clinicians. He has published almost 300 papers in his career and has over 29,000 totol citations, with an excellent h-index of 70.
Caracteristici
Comprehensive coverage how genetic targets impacts cancer therapy over a full spectrum of different cancers Contributors are top experts on their topics An emerging trend in cancer is an interest in the impact of genetic targets to current cancer therapies Includes supplementary material: sn.pub/extras